Advanced Micro Devices
AMD
ASML Holding
ASML
Meta Platforms
META
Cisco
CSCO
Taiwan Semiconductor
TSM
US Stock MarketDetailed Quotes
XCUR Exicure
- 17.5800
- +0.3300+1.91%
Close Dec 27 16:00 ET
- 17.0100
- -0.5700-3.24%
Post 20:01 ET
53.43MMarket Cap-8.70P/E (TTM)
18.4277High16.3999Low127.27KVolume17.7500Open17.2500Pre Close2.18MTurnover7.99%Turnover RatioLossP/E (Static)3.04MShares36.000052wk High34.61P/B28.00MFloat Cap1.440052wk Low--Dividend TTM1.59MShs Float576.0000Historical High--Div YieldTTM11.76%Amplitude1.4400Historical Low17.1150Avg Price1Lot Size
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Exicure Stock Forum
Exicure (XCUR) has signed an MOU with GPCR Therapeutics to acquire its US subsidiary, GPCR USA, and collaborate on drug development pipelines. The deal includes technology transfer of GPCR's CXCR4 inhibitor, currently in Phase 2 clinical trials, with an estimated market size of $1-2 billion annually. The acquisition targets multiple myeloma and acute myeloid leukemia (AML) treatments.
The company has secured total funding of $12 million ($8.7M on Dec 24, $2M on Dec 9, ...
Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech
Thursday, 26th December at 8:08 pm
Exicure, Inc. (NASDAQ: XCUR, "Exicure", "the Company")), has announced the signing of a Memorandum of Understanding (MOU) with GPCR Therapeutics, Inc. ("GPCR Therapeutics") on December 24, 2024, aimed at the acquisition of GPCR USA, a subsidiary of GPCR Therapeutics, and the technology transfer and collaborative research on GPCR Therapeutics' ongoing drug developm...
Exicure Inc: On Dec 20, Co Received Nasdaq Letter Confirming That as of Dec 17, Co Meets All Requirements for Continued Listing on Nasdaq
Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes
Friday, 20th December at 4:42 pm
Exicure, Inc. (NASDAQ: XCUR, "the Company", "Exicure")), today announced that in connection with the change of control transaction approved by the stockholders at the Special Meeting of the Stockholders on December 17, 2024 (the "Change of Control"), the stockholders of the Company approved a second investment of...
Top Performing Cryptocurrencies:
1. XRP (XRP): Approximately 309.86% gain.
2. Stellar (XLM): Approximately 390.92% gain.
3. Verge (XVG): Approximately 277.85% gain.
4. SecretCoin (SCRT): Approximately 222.48% gain.
5. IOTA (MIOTA): Approximately 287.04% gain.
6. EOS (EOS): Approximately 174.33% gain.
7. VeChain (VET): Approximately 197.40% gain.
Source: CryptocurrencyChart.com
Top Performing Stocks:
1. Wearable Devices (WLDSW): Approxim...
📊⚡️📊
📊⚡️📊
$Poseida Therapeutics (PSTX.US)$ ✔️TOP PLAY. To be acquired by Roche for $1.5B for $9.00/share. “Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $4.00 per share in cash”
$Citius Pharmaceuticals (CTXR.US)$✔️ News halt after hours + PR today o...
No comment yet